Patent · US Active

Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis

US10082496B2 · kind B2 · utility

0Cited by
11References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 5, 2016
Grant dateSep 25, 2018
Priority date—
Expiry dateJul 5, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/99
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The described invention provides methods for targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.